David Veyer

11.2k total citations
53 papers, 846 citations indexed

About

David Veyer is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, David Veyer has authored 53 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 19 papers in Infectious Diseases and 16 papers in Surgery. Recurrent topics in David Veyer's work include Cervical Cancer and HPV Research (23 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and SARS-CoV-2 detection and testing (12 papers). David Veyer is often cited by papers focused on Cervical Cancer and HPV Research (23 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and SARS-CoV-2 detection and testing (12 papers). David Veyer collaborates with scholars based in France, Gabon and Democratic Republic of the Congo. David Veyer's co-authors include Hélène Péré, Laurent Bélec, Geoffrey L. Smith, Carlos Maluquer de Motes, Rebecca P. Sumner, Maxime Wack, Guia Carrara, Ralph‐Sydney Mboumba Bouassa, Isabelle Podglajen and Cécile Badoual and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

David Veyer

52 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Veyer France	18	356	322	166	142	111	53	846
Bornali Bhattacharjee India	12	602 1.7×	116 0.4×	62 0.4×	182 1.3×	85 0.8×	22	782
Gerald Corbitt United Kingdom	14	411 1.2×	127 0.4×	145 0.9×	76 0.5×	63 0.6×	38	701
Valentina Militello Italy	11	259 0.7×	207 0.6×	80 0.5×	136 1.0×	33 0.3×	14	607
Michele Till United States	12	242 0.7×	320 1.0×	63 0.4×	110 0.8×	113 1.0×	18	729
Masahiro Watanabe Japan	18	332 0.9×	152 0.5×	122 0.7×	139 1.0×	188 1.7×	71	828
Somayeh Jalilvand Iran	20	512 1.4×	466 1.4×	196 1.2×	164 1.2×	75 0.7×	98	1.1k
Hacène Khiri France	22	958 2.7×	333 1.0×	108 0.7×	181 1.3×	42 0.4×	62	1.3k
Jaythoon Hassan Ireland	22	412 1.2×	204 0.6×	74 0.4×	124 0.9×	530 4.8×	63	1.3k
Karine Bolloré France	18	321 0.9×	398 1.2×	40 0.2×	61 0.4×	147 1.3×	43	830
Snježana Židovec Lepej Croatia	17	378 1.1×	390 1.2×	65 0.4×	77 0.5×	121 1.1×	101	947

Countries citing papers authored by David Veyer

Since Specialization

Citations

This map shows the geographic impact of David Veyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Veyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Veyer more than expected).

Fields of papers citing papers by David Veyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Veyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Veyer. The network helps show where David Veyer may publish in the future.

Co-authorship network of co-authors of David Veyer

This figure shows the co-authorship network connecting the top 25 collaborators of David Veyer. A scholar is included among the top collaborators of David Veyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Veyer. David Veyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hingrat, Quentin Le, P. Catoire, Richard Chocron, et al.. (2025). Comparison of patients presenting to emergency departments infected with respiratory syncytial virus versus influenza virus: A retrospective cohort study. Journal of Clinical Virology. 177. 105775–105775. 1 indexed citations

Blanchard, Pierre, Anne Aupérin, David Veyer, et al.. (2025). Intensification or de-escalation? What is the standard treatment for human papillomavirus-related oropharyngeal cancers in 2025?. Cancer/Radiothérapie. 29(5-6). 104674–104674. 1 indexed citations

Mirghani, H., Anne Aupérin, Odile Casiraghi, et al.. (2024). HPV-driven oropharyngeal cancer burden in Paris and its region (ILE DE FRANCE) from 1981 TO 2021. Cancer Epidemiology. 91. 102603–102603. 1 indexed citations

Flahault, Adrien, David Veyer, Alexandre Karras, et al.. (2023). Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases. Clinical Rheumatology. 42(9). 2485–2490. 2 indexed citations

Bouassa, Ralph‐Sydney Mboumba, Serge Tonen‐Wolyec, David Veyer, Hélène Péré, & Laurent Bélec. (2022). Analytical performances of the AMPLIQUICK® Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens. PLoS ONE. 17(1). e0262258–e0262258. 9 indexed citations

Péré, Hélène, Jérôme Fayette, L. Geoffrois, et al.. (2022). 653O Neoadjuvant nivolumab (N) before chemoradiation (CRT) in high-risk HPV driven oropharynx cancer (OPC) - IMMUNEBOOST-HPV: A multicenter randomized phase II trial. Annals of Oncology. 33. S840–S841. 5 indexed citations

Wack, Maxime, Hélène Péré, Najiby Kassis‐Chikhani, et al.. (2021). No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris. Journal of Clinical Virology. 145. 104999–104999. 3 indexed citations

Champigneulle, Benoît, Stéphane Doutreleau, Émeric Stauffer, et al.. (2021). High-Altitude Environment and COVID-19: SARS-CoV-2 Seropositivity in the Highest City in the World. High Altitude Medicine & Biology. 25(3). 218–222. 5 indexed citations

Bouassa, Ralph‐Sydney Mboumba, et al.. (2021). High Prevalence of Anal Oncogenic Human Papillomavirus Infection in Young Men Who Have Sex with Men Living in Bamako, Mali. Infectious Agents and Cancer. 16(1). 51–51. 10 indexed citations

10.

Bouassa, Ralph‐Sydney Mboumba, et al.. (2021). Correction: High Prevalence of Anal Oncogenic Human Papillomavirus Infection in Young Men Who Have Sex with Men Living in Bamako, Mali. Infectious Agents and Cancer. 16(1). 2 indexed citations

11.

Péré, Hélène, Ralph‐Sydney Mboumba Bouassa, Serge Tonen‐Wolyec, et al.. (2021). Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests. Journal of Virological Methods. 290. 114067–114067. 13 indexed citations

12.

Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations

13.

Péré, Hélène, Benoı̂t Vedie, Raphaël Vernet, et al.. (2020). Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology. Journal of Clinical Virology. 132. 104568–104568. 5 indexed citations

14.

Péré, Hélène, C. Gubavu, Thiérry Prazuck, et al.. (2020). Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. PLoS ONE. 15(5). e0233084–e0233084. 2 indexed citations

15.

Neuzillet, Cindy, Maxime Wack, Sonia Lameiras, et al.. (2019). Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell Carcinomas. Cancers. 11(12). 1846–1846. 18 indexed citations

16.

Péré, Hélène, David Veyer, Mathieu Matta, et al.. (2019). High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N’Djamena, Chad. PLoS ONE. 14(6). e0217486–e0217486. 19 indexed citations

17.

Pernot, Simon, Pauline Boucheron, Hélène Péré, et al.. (2018). Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men. British Journal of Cancer. 119(3). 381–386. 32 indexed citations

18.

Augustin, Jérémy, Marion Mandavit, Thomas Denize, et al.. (2018). Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas. Human Pathology. 78. 63–71. 27 indexed citations

19.

Veyer, David, Guia Carrara, Carlos Maluquer de Motes, & Geoffrey L. Smith. (2017). Vaccinia virus evasion of regulated cell death. Immunology Letters. 186. 68–80. 52 indexed citations

20.

Revest, Matthieu, S. Minjolle, David Veyer, et al.. (2011). Detection of HHV-6 in over a thousand samples: New types of infection revealed by an analysis of positive results. Journal of Clinical Virology. 51(1). 20–24. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact